Horm Metab Res 2009; 41(7): 554-558
DOI: 10.1055/s-0029-1192034
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

Cholesteryl Ester Transfer Protein I405V Polymorphism Influences Apolipoprotein A-I Response to a Change in Dietary Fatty Acid Composition

M. Darabi 1 , A. A. Abolfathi 1 , M. Noori 1 , A. Kazemi 2 , A. Ostadrahimi 2 , A. Rahimipour 1 , M. Darabi 3 , K. Ghatrehsamani 1
  • 1Department of Biochemistry, School of Medicine, Tabriz University (Medical Sciences), Tabriz, Iran
  • 2Nutritional Research Center, Tabriz University (Medical Sciences), Tabriz, Iran
  • 3Department of Biochemistry, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
Further Information

Publication History

received 25.10.2008

accepted 07.01.2009

Publication Date:
25 February 2009 (online)

Abstract

The aim of the present study was to investigate whether the cholesteryl ester transfer protein (CETP) I405V polymorphism modifies the response to changes in the dietary ratio of polyunsaturated to saturated fat (P:S). The population included 85 healthy subjects with the different I405V genotypes (35 II, 36 IV, and 14 VV) assigned to two consecutive 28-day experimental period. All subjects consumed a high-P:S with P:S of 1.2 for the first period and a low-P:S with a P:S of 0.3 for the next 28-day period. At the first and end of each dietary period, serum lipid, lipoprotein, and CETP concentrations were measured. At screening, lipid or lipoprotein concentrations were not significantly different among CETP I405V genotype groups. After the low-P:S diet, subjects carrying V allele had greater reduction in apoA-I and HDL cholesterol (HDL-C) than subjects with II genotype. A genotype-by-diet interaction effect was observed on apoA-I (p=0.016) concentrations. In conclusion, the CETP I405V polymorphism contributes to the unfavorable changes of apoA-I and HDL-C when a high-P:S diet was replaced with a low-P:S diet.

References

  • 1 Ordovas JM. Genetic interactions with diet influence the risk of cardiovascular disease.  Am J Clin Nutr. 2006;  83 443S-446S
  • 2 Petrella RJ, Merikle E, Jones J. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.  Clin Ther. 2007;  29 742-750
  • 3 Bruce C, Chouinard Jr RA, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport.  Annu Rev Nutr. 1998;  18 297-330
  • 4 Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.  N Engl J Med. 1990;  323 1234-1238
  • 5 Tall AR, Yvan-Charvet L, Wang N. The failure of torcetrapib: was it the molecule or the mechanism?.  Arterioscler Thromb Vasc Biol. 2007;  27 257-260
  • 6 Tchoua U, D'Souza W, Mukhamedova N, Blum D, Niesor E, Mizrahi J, Maugeais C, Sviridov D. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.  Cardiovasc Res. 2008;  77 732-739
  • 7 Rye KA, Duong M, Psaltis MK, Curtiss LK, Bonnet DJ, Stocker R, Barter PJ. Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.  Biochemistry. 2002;  41 12538-12545
  • 8 Groener JE, Ramshorst EM van, Katan MB, Mensink RP, van TA. Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects.  Atherosclerosis. 1991;  87 221-226
  • 9 Boekholdt SM, Kuivenhoven JA, Hovingh GK, Jukema JW, Kastelein JJ, van TA. CETP gene variation: relation to lipid parameters and cardiovascular risk.  Curr Opin Lipidol. 2004;  15 393-398
  • 10 Pallaud C, Gueguen R, Sass C, Grow M, Cheng S, Siest G, Visvikis S. Genetic influences on lipid metabolism trait variability within the Stanislas Cohort.  J Lipid Res. 2001;  42 1879-1890
  • 11 Thompson A, Di AE, Sarwar N, Erqou S, Saleheen D, Dullaart RP, Keavney B, Ye Z, Danesh J. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.  JAMA. 2008;  299 2777-2788
  • 12 Borggreve SE, Hillege HL, Wolffenbuttel BH, Jong PE de, Zuurman MW, Steege G van der, Tol A van, Dullaart RP. PREVEND Study Group . An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.  J Clin Endocrinol Metab. 2006;  91 3382-3388
  • 13 Teran-Garcia M, Despres JP, Tremblay A, Bouchard C. Effects of cholesterol ester transfer protein (CETP) gene on adiposity in response to long-term overfeeding.  Atherosclerosis. 2008;  196 455-460
  • 14 Keys A, Parlin RW. Serum cholesterol response to changes in dietary lipids.  Am J Clin Nutr. 1966;  19 175-181
  • 15 Assmann G, Schriewer H, Schmitz G, Hagele EO. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2.  Clin Chem. 1983;  29 2026-2030
  • 16 Rifai N, Warnick GR. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry. Philadelphia: Elsevier Saunders 2006: 903-968
  • 17 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.  Clin Chem. 1972;  18 499-502
  • 18 Noori M, Darabi M, Rahimipour A, Rahbani M, Aslan-Abadi N, Darabi M, Ghatrehsamani K. Fatty acid composition of HDL phospholipids and coronary artery disease.  J Clin Lipidol. 2008;  , [In Press], doi:10.1016/j.jacl.2008.11.010
  • 19 Padmaja N, Ravindra KM, Soya SS, Adithan C. Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population.  Clin Chim Acta. 2007;  375 140-146
  • 20 Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Gualtieri LJ, Goldin BR, Ordovas JM, Schaefer EJ. Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a National Cholesterol Education Program Step 2 diet.  Arterioscler Thromb. 1993;  13 1533-1542
  • 21 Vega GL, Groszek E, Wolf R, Grundy SM. Influence of polyunsaturated fats on composition of plasma lipoproteins and apolipoproteins.  J Lipid Res. 1982;  23 811-822
  • 22 Dorfman SE, Wang S, Vega-Lopez S, Jauhiainen M, Lichtenstein AH. Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters.  J Nutr. 2005;  135 492-498
  • 23 Marzuki A, Arshad F, Razak TA, Jaarin K. Influence of dietary fat on plasma lipid profiles of Malaysian adolescents.  Am J Clin Nutr. 1991;  53 1010S-1014S
  • 24 Zhang J, Wang CR, Xue AN, Ge KY. Effects of red palm oil on serum lipids and plasma carotenoids level in Chinese male adults.  Biomed Environ Sci. 2003;  16 348-354
  • 25 Kushwaha RS, Reardon CA, Lewis DS, Qi Y, Rice KS, Getz GS, Carey KD, MacGill  Jr  HC. Effect of dietary lipids on plasma activity and hepatic mRNA levels of cholesteryl ester transfer protein in high- and low-responding baboons (Papio species).  Metabolism. 1994;  43 1006-1012
  • 26 Friedlander Y, Leitersdorf E, Vecsler R, Funke H, Kark J. The contribution of candidate genes to the response of plasma lipids and lipoproteins to dietary challenge.  Atherosclerosis. 2000;  152 239-248
  • 27 Chang NW, Wu CT, Chen FN, Huang PC. High polyunsaturated and monounsaturated fatty acid to saturated fatty acid ratio increases plasma very low density lipoprotein lipids and reduces the hepatic hypertriglyceridemic effect of dietary cholesterol in rats.  Nutr Res. 2004;  24 73-83
  • 28 Pietzsch J, Julius U, Nitzsche S, Hanefeld M. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.  Diabetes. 1998;  47 1928-1934
  • 29 Guérin M, Le Goff W, Lassel TS, Tol A Van, Steiner G, Chapman MJ. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.  Arterioscler Thromb Vasc Biol. 2001;  21 282-288

Correspondence

M. Darabi

Department of Biochemistry

School of Medicine

Tabriz University (Medical Sciences)

Golgasht Avenue

Tabriz

Iran

Phone: +98/411/336 46 66

Fax: +98/411/336 46 66

Email: mdarabi@hotmail.com

    >